Maternal plasma fetuin-A levels in fetal growth restriction: A case-control study.

Fetuin-A Pregnancy. Fetal growth restriction

Journal

International journal of reproductive biomedicine
ISSN: 2476-4108
Titre abrégé: Int J Reprod Biomed
Pays: Iran
ID NLM: 101679102

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 23 06 2018
revised: 24 12 2018
accepted: 30 04 2019
entrez: 12 9 2019
pubmed: 12 9 2019
medline: 12 9 2019
Statut: epublish

Résumé

Higher Fetuin-A (FA) concentrations were found to be associated with obesity and there is an interest to the relation between maternal FA and pregnancy outcomes. In this study, our aim was to evaluate the association of maternal plasma levels of FA with fetal growth restriction (FGR). 41 pregnant women with FGR and 40 controls were recruited in this case-control study between July and November 2015. At the diagnosis of FGR, venous blood samples (10 cc) were obtained for FA analysis. Maternal plasma FA levels were significantly higher in fetal growth-restricted pregnant women compared with controls (19.3 The results of this study show higher maternal plasma levels of FA in FGR. Further studies are needed in order to demonstrate the long-term effects of FA in pregnancies complicated with FGR and early prediction of FGR.

Sections du résumé

BACKGROUND BACKGROUND
Higher Fetuin-A (FA) concentrations were found to be associated with obesity and there is an interest to the relation between maternal FA and pregnancy outcomes.
OBJECTIVE OBJECTIVE
In this study, our aim was to evaluate the association of maternal plasma levels of FA with fetal growth restriction (FGR).
MATERIALS AND METHODS METHODS
41 pregnant women with FGR and 40 controls were recruited in this case-control study between July and November 2015. At the diagnosis of FGR, venous blood samples (10 cc) were obtained for FA analysis.
RESULTS RESULTS
Maternal plasma FA levels were significantly higher in fetal growth-restricted pregnant women compared with controls (19.3
CONCLUSION CONCLUSIONS
The results of this study show higher maternal plasma levels of FA in FGR. Further studies are needed in order to demonstrate the long-term effects of FA in pregnancies complicated with FGR and early prediction of FGR.

Identifiants

pubmed: 31508574
doi: 10.18502/ijrm.v17i7.4860
pmc: PMC6718885
doi:

Types de publication

Journal Article

Langues

eng

Pagination

487-492

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

J Comp Physiol B. 1992;162(2):168-71
pubmed: 1375608
Educ Health (Abingdon). 2003 Jul;16(2):230
pubmed: 14741909
Circulation. 2006 Apr 11;113(14):1760-7
pubmed: 16567568
Clin Obstet Gynecol. 2006 Jun;49(2):257-69
pubmed: 16721105
Mol Cell Proteomics. 2008 Mar;7(3):591-9
pubmed: 18065755
Cytokine. 2008 Dec;44(3):323-7
pubmed: 18922701
Circulation. 2008 Dec 9;118(24):2555-62
pubmed: 19029462
J Matern Fetal Neonatal Med. 2008 Nov;21(11):826-30
pubmed: 19031279
Eur Heart J. 2009 Aug;30(16):2054-61
pubmed: 19429630
J Matern Fetal Neonatal Med. 2009 Jun;22(6):501-9
pubmed: 19479639
Shock. 2009 Jul;32(1):17-22
pubmed: 19533845
Atherosclerosis. 2010 Jan;208(1):290-6
pubmed: 19709661
Am J Obstet Gynecol. 2012 Dec;207(6):484.e1-8
pubmed: 23108067
Ultrasound Obstet Gynecol. 2013 Aug;42(2):201-6
pubmed: 23303527
Obstet Gynecol. 2013 May;121(5):1122-33
pubmed: 23635765
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
J Gynecol Obstet Biol Reprod (Paris). 2013 Dec;42(8):895-910
pubmed: 24216305
Hum Reprod. 2014 Oct 10;29(10):2333-8
pubmed: 24963163
J Obstet Gynaecol. 2015 Jan;35(1):9-12
pubmed: 24999531
Arch Gynecol Obstet. 2015 Apr;291(4):933-7
pubmed: 25260988
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Sep;159(3):352-9
pubmed: 25916279
Pregnancy Hypertens. 2012 Jul;2(3):201-2
pubmed: 26105259
Ultrasound Obstet Gynecol. 2016 Sep;48(3):333-9
pubmed: 26909664
Eur J Obstet Gynecol Reprod Biol. 2016 May;200:108-12
pubmed: 27017530
Am J Perinatol. 2016 Dec;33(14):1337-1356
pubmed: 27159203
Geburtshilfe Frauenheilkd. 2017 May;77(5):516-523
pubmed: 28579623
Int J Reprod Biomed (Yazd). 2017 Mar;15(3):135-140
pubmed: 28580445
Mol Endocrinol. 1993 Nov;7(11):1445-55
pubmed: 7906861

Auteurs

Mujde Can Ibanoglu (M)

University of Health Sciences, Dr. Zekai Tahir Burak Women's Health Care, Education and Research Hospital, Ankara, Turkey.

Cem Yasar Sanhal (C)

University of Health Sciences, Dr. Zekai Tahir Burak Women's Health Care, Education and Research Hospital, Ankara, Turkey.

Seval Ozgu-Erdinc (S)

University of Health Sciences, Dr. Zekai Tahir Burak Women's Health Care, Education and Research Hospital, Ankara, Turkey.

Ozgur Kara (O)

University of Health Sciences, Dr. Zekai Tahir Burak Women's Health Care, Education and Research Hospital, Ankara, Turkey.

Aykan Yucel (A)

University of Health Sciences, Dr. Zekai Tahir Burak Women's Health Care, Education and Research Hospital, Ankara, Turkey.

Dilek Uygur (D)

University of Health Sciences, Dr. Zekai Tahir Burak Women's Health Care, Education and Research Hospital, Ankara, Turkey.

Classifications MeSH